#new SARS-CoV-2 strain

[survivingcapitalism]

Worldwide, there were more than 11,000 reported deaths from COVID between mid-December 2023 and mid-January 2024, and more than half of those deaths occurred in the U.S. In that same time frame, nearly one million cases were reported to the World Health Organization globally (although reduced testing and reporting means this is likely a vast undercount). In particular, epidemiologists are monitoring the newest variant of SARS-CoV-2, JN.1, and looking for any signs that it may be more severe than previous strains.

Although the WHO declared an end to the COVID public health emergency in May 2023, the organization has emphasized that the pandemic isn’t over—it’s just entered an endemic phase, which means that the virus will continue to circulate indefinitely.

[...]

How would you describe the overall state of COVID at this point in the pandemic?

COVID’s not in the news every day, but it’s still a global health risk. If we look at wastewater estimates, the actual circulation [of SARS-CoV-2] is somewhere between two and 20 times higher than what’s actually being reported by countries. The virus is rampant. We’re still in a pandemic. There’s a lot of complacency at the individual level, and more concerning to me is that at the government level.

[...]

"We understand you don’t want to hear about it. I don’t want to talk about it. But we need to because there’s more we can do. We cannot prevent all infections. We cannot prevent all deaths. But there’s a hell of a lot more that we can do to keep people safe and save them from losing a loved one"

[iwan1979]

Researchers from Peking University, Beijing in a new study have found that the new SARS-CoV-2 recombinant variant XBB is the most immune evasive strain to date that is almost comparable to the lethal SARS-CoV-1 strain that made its short debut in 2003.   The XBB sub-lineage is a recombinant variant...

#BREAKING! Chinese Researchers Warn That New SARS-CoV-2 Recombinant Variant XBB Is The Most Immune Evasive Strain That Is Comparable To The S

[renthony]

From the article:

For four years now, either as a physical virus or as a looming threat, the COVID-causing pathogen SARS-CoV-2 has been the elephant in every room—sometimes confronted and sometimes ignored but always present. While once we dreamed of eradicating COVID, now much of society has resigned itself to SARS-CoV-2’s constant presence—a surrender that would once have been unthinkable. Worldwide, there were more than 11,000 reported deaths from COVID between mid-December 2023 and mid-January 2024, and more than half of those deaths occurred in the U.S. In that same time frame, nearly one million cases were reported to the World Health Organization globally (although reduced testing and reporting means this is likely a vast undercount). In particular, epidemiologists are monitoring the newest variant of SARS-CoV-2, JN.1, and looking for any signs that it may be more severe than previous strains.

#covid news #covid

[mindblowingscience]

The findings, published in the Journal of the Royal Society Interface today, reveal how cleaner air kills the virus significantly quicker and why opening a window may be more important than originally thought. The research could shape future mitigation strategies for new viruses. In the first study to measure differences in airborne stability of different variants of SARS-CoV-2 in inhalable particles, researchers from Bristol's School of Chemistry show that the virus has become less capable of surviving in the air as it has evolved from the original strain through to the delta variant. Dr. Allen Haddrell, the study's lead author and Senior Research Associate in Bristol's School of Chemistry, explained, "Aerosol particles, exhaled when infected individuals breathe, speak or cough, can transmit viruses—but how and why viruses lose infectivity once they are circulating around in these airborne particles has been widely debated."

Continue Reading

#science #stem #biology #viruses #virology #biochemistry

[why-animals-do-the-thing]

Infectious disease, captive animals, and the Endangered Species Act

There's been a really interesting development in how the Endangered Species Act relates to captive animals in the United States. I picked up on it last fall and spent most of the early part of this year writing a paper about what happened and what implications it might have in the future - but what I didn't expect was to proved right within a month!

Basically, two different lower court judges have ruled recently that exposing captive endangered animals to an increased risk of infectious disease is a violation of the Endangered Species Act. They don’t actually have to get sick - just the fact that the risk wasn’t prevented qualifies. This has super huge implications for zoos and sanctuaries and anywhere else with an endangered species collection. Both lawsuits (one about a lemur, and one about some of the tiger king lions) resulted in major consequences: the lemurs were seized, and since the lions had already been removed prior to that lawsuit, the guy involved got hit with major penalties and prohibitions for the future.

Where I think this potentially creates the most immediate issue is, of course, SARS-CoV-2. Most zoological facilities are ending their requirements for staff to mask and socially distance around susceptible species (and holy heck, I was not aware how many species can get sick from it). This is especially a huge concern for big cats, since they seem to be the most at risk. The ESA lawsuit from 2020, against Jeff Lowe for his treatment of lion cubs, specifically notes that it was a violation for him to not follow “generally accepted” risk mitigation procedures, specifically, not masking and not distancing. So does that mean that zoos and sanctuaries that are having staff stop masking around tigers and lions and snow leopards are violating the ESA? We don’t know for sure, but it’s entirely possible.

The reason we don’t know is that the scope of the ESA is being changed by the interpretation of the courts. Rather than getting amendments passed, or having FWS choose to consider certain things violations, these judges are basically ruling on what they see as a violation of their understanding of the law. And those precedents can have some pretty serious impacts. Other judges aren’t required to rule the same way on similar topics (as long as they’re not in the same district, and a lower court, than the original ruling) but they often take previous precedents on the topic into pretty serious consideration. So for example, the argument that not masking around the lions was based on a precedent from the previous case, where it was ruled that having a lemur living in a situation that made it more likely to get sick was also a violation. So in the next case, courts could choose to agree with the lion and lemur precedents - or not - and we don’t know for sure until it’s litigated. Sigh.

But here’s the thing: there’s plenty of other zoonotic diseases that captive animals have to be protected from. I wrote my paper originally about SARS-CoV-2, but noted at the end that “While SARS-CoV-2 was the zoonotic disease risk during the [lion] court case, it is important to recognize that the ESA violations identified by the courts in that lawsuit and in [the lemur court case] were on the topic of increased or unmitigated disease risk more generally. This new scope of the ESA captive take provision may be relevant to other circulating zoonotic pathogens; for instance, the H5N1 strain of avian influenza has recently proven to be fatal to tigers, mustelids, and some marine mammal species.” I realized after publication that it could be argued that EEHV - the really deadly elephant hemorrhagic herpes virus - might also fall under the scope of these rulings.

And surprise! A couple days ago, it made the news that the Noah’s Ark Animal Sanctuary in Georgia was told to change their practices or be sued for violating the ESA. Some of the allegations? That the facility “failed to prevent tigers and a lion from exposure to the potentially deadly Avian Influenza virus.” I expected to see additional claims in ESA lawsuits about infectious disease risk - I just didn’t expect to see them so quickly after I published a big project warning about the possibility.

I don’t have a sense of where this issue will continue to go from here, as each additional court decisions changes how the precedent might have impacts. But I do think it’s going to be important to pay attention to, and might have pretty big impacts on how facilities handle zoonotic disease moving forwards.

A link to the full 13-page paper on the legal precedents - and my concerns about the impact of ending SARS-CoV-2 precautions around endangered animals - is below.

#endangered species #zoo management #zoos #tigers #lions #zoonosis #endangered species act lawsuit #litigation #covid #HPAI

[fabricdragondesigns]

Even with a new booster, the XBB.1.5 vaccine offered no increased protection from infection against the JN.1 variant. This alarming discovery underscores the virus's relentless ability to mutate and evade our defenses, fueling continued transmission, evolution, and the devastating threat of Long COVID.

"Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity"

(March 07, 2024)

"However, progressive loss of neutralization was observed across newer variants, irrespective of vaccine doses. Importantly, an updated XBB.1.5 booster significantly increased titers against newer variants but not JN.1. These findings demonstrate that seasonal boosters improve titers against contemporaneous strains, but novel variants continue to evade updated mRNA vaccines, demonstrating the need for novel approaches to adequately control SARS-CoV-2 transmission."

#covid #vaccines #new variant #mutation #immunity

[allthebrazilianpolitics]

New strain of Covid-19 detected in Brazil

Brazilian authorities Monday confirmed the detection of four cases of the JN 2.5 subvariant of the SARS-Cov-2 virus in the state of Mato Grosso. The patients were reported to be all female and hospitalized in a serious condition. One of them even died. However, the Mato Grosso State Health Department said there was no reason to panic because at this point “it is not possible to say that the cause of death was COVID-19” since ”the patient already had chronic obstructive pulmonary disease (COPD).”

The infections were confirmed through testing by the State's Central Laboratory between Jan. 16 and 18. The new strain, a variation of Omicron, had already been found in Canada, France, Poland, Spain, the United States, Sweden, and the United Kingdom.

The other three patients have already been discharged, are stable, and remain in home isolation under the supervision of the Municipal Surveillance Department of an undisclosed location.

In this scenario, people were advised to wear a facemask when suffering from flu-like symptoms “in addition to washing your hands with soap and/or sanitizing them with 70% alcohol.

Continue reading.

#brazil #brazilian politics #politics #coronavirus #covid 19 #mod nise da silveira #image description in alt

[mariacallous]

Chinese Hospitals Are Housing Another Deadly Outbreak

In Beijing and other megacities in China, hospitals are overflowing with children suffering pneumonia or similar severe ailments. However, the Chinese government claims that no new pathogen has been found and that the surge in chest infections is due simply to the usual winter coughs and colds, aggravated by the lifting of stringent COVID-19 restrictions in December 2022. The World Health Organization (WHO) has dutifully repeated this reassurance, as if it learned nothing from Beijing’s disastrous cover-up of the COVID-19 outbreak.

There is an element of truth in Beijing’s assertion, but it is only part of the story. The general acceptance that China is not covering up a novel pathogen this time appears reassuring. In fact, however, China could be incubating an even greater threat: the cultivation of antibiotic-resistant strains of a common, and potentially deadly, bacteria.

Fears of another novel respiratory pathogen emerging from China are understandable after the SARS and COVID-19 pandemics, both of which Beijing covered up. Concerns are amplified by Beijing’s ongoing obstruction of any independent investigation into the origins of SARS-CoV-2, the virus that causes COVID-19—whether it accidentally leaked from the Wuhan lab performing dangerous gain-of-function research or derived from the illegal trade in racoon dogs and other wildlife at the now-infamous Wuhan wet-market.

Four years ago, during the early weeks of the COVID-19 outbreak, Beijing failed to report the new virus and then denied airborne spread. At pains to maintain their fiction, Chinese authorities punished doctors who raised concerns and prohibited doctors from speaking even to Chinese colleagues, let alone international counterparts. Chinese medical statistics remain deeply unreliable; the country still claims that total COVID-19 deaths sit at just over 120,000, whereas independent estimates suggest the number may have been over 2 million in just the initial outbreak alone. Now, Chinese doctors are once again being silenced and not communicating with their counterparts abroad, which suggests another potentially dangerous cover-up may be underway.

We don’t know exactly what is happening, but we can offer some informed guesses.

The microbe causing the surge in hospitalization of children is Mycoplasma pneumoniae, which causes M. pneumoniae pneumonia, or MPP. First discovered in 1938, the microbe was believed for decades to be a virus because of its lack of a cell membrane and tiny size, although in fact it is an atypical bacterium. These unusual characteristics makes it invulnerable to most antibiotics (which typically work by destroying the cell membrane). The few attempts to make a vaccine in the 1970s failed, and low mortality has provided little incentive for renewed efforts. Although MPP surges are seen every few years around the world, the combination of low mortality and difficult diagnostics has meant there is no routine surveillance.

Although MPP is the most common cause of community-acquired pneumonia in school children and teenagers, pediatricians such as myself refer to it as “walking pneumonia” because symptoms are relatively mild. Respiratory Syncytial Virus (RSV), influenza, adenoviruses, and rhinoviruses (also known as the common cold) all cause severe inflammation of the lungs and are far more common causes of emergency-room visits, hospitalization, and death in infants and young children. Why should MPP be acting differently now?

One contributing factor to the severity of this outbreak may be “immunity debt.” Around the globe, COVID-19 lockdowns and other non-pharmaceutical measures meant that children were less exposed to the usual range of pathogens, including MPP, for several years. Many countries have since seen rebound surges in RSV. Several experts agree with Beijing’s explanation that the combination of winter’s arrival, the end of COVID-19 restrictions, and a lack of prior immunity in children are likely behind the surging infections. Some even speculate that that substantial lockdown may have particularly compromised young children’s immunity, because exposure to germs in infancy is essential for immune systems to develop.

In China, MPP infections began in early summer and accelerated. By mid-October, the National Health Commission had taken the unusual step of adding MPP to its surveillance system. That was just after Golden Week, the biggest tourism week in China.

Infection by two diseases at the same time can make things worse. The usual candidates for coinfection in children—RSV and flu—have not previously caused comparable surges in pneumonia. One difference this time is COVID-19. It is possible that the combination of COVID-19 and MPP is particularly dangerous. Although adults are less susceptible to MPP due to years of exposure, adults hospitalized for COVID-19 who were simultaneously or recently coinfected by MPP had a significantly higher mortality rate, according to a 2020 study.

Infants and toddlers are immunologically naive to MPP, and unlike COVID-19, RSV, and influenza, there is no vaccine against MPP. It seems implausible that no child (or adult) has died from MPP, yet China has not released any data on mortality, or on extrapulmonary complications such as meningitis.

Most disturbing, and a fact being downplayed by Beijing, is that M. pneumoniae in China has mutated to a strain resistant to macrolides, the only class of antibiotics that are safe for children less than eight years of age. Beyond discouraging parents to start ad hoc treatment with azithromycin, the most common macrolide and the usual first-line antibiotic for MPP, Beijing has barely mentioned this fact. Even more worrying is that WHO has assessed the risk of the current outbreak as low on the basis that MPP is readily treated with antibiotics. Broader azithromycin resistance in MPP is common across the world, and China’s resistant strain rates in particular are exceptionally high. Beijing’s Centers for Disease Control and Prevention reported macrolide resistance rates for MPP in the Beijing population between 90 and 98.4 percent from 2009 to 2012. This means there is no treatment for MPP in children under age eight.

Fears over a novel pathogen are already abating. After all, MPP is rarely lethal. But antimicrobial resistance (AMR) is. Responsible for 1.3 million deaths a year, AMR kills more people than COVID-19. No country is immune to this growing threat. Since China, where antibiotics are regularly available over the counter, leads the world in AMR, it is inconceivable that this issue hasn’t yet come up, particularly during WHO’s World AMR Awareness week, from Nov. 18 to Nov. 24.

Any infectious disease physician would want to know: Did WHO asked China the obvious question—what is the level of azithromycin resistance of M. pneumonia in the current outbreak—and include the answer in its risk assessment? Or did it ask about resistance to doxycycline and quinolones, antibiotics that can be used to treat MPP in adults? Even if WHO did ask, China isn’t telling, and WHO isn’t talking.

China’s silence isn’t surprising. Its antibiotic consumption per person is ten times that of the United States, and policies for AMR stewardship are predominantly cosmetic. While surveillance is China’s strong point, reporting is not.

Despite Spring Festival, the Chinese celebration of the Lunar New Year and another peak travel period, approaching in February 2024, WHO hasn’t advised any travel restrictions. It should have learned the danger of accepting Beijing’s statements at face value. Four years ago, Beijing’s delay enabled more than 200 million people to travel from and through Wuhan for Spring Festival. That helped COVID-19 go global. Since China’s AMR rates are already so high, importing AMR from other countries isn’t a major concern for China. Export is the issue, and China’s track record in protecting other countries is abysmal.

Rather than repeating the self-serving whitewashing coming from Beijing, WHO should be publicly pressing China about the threat of mutant microbes. Halting AMR is essential. Before antisepsis and antibiotics, surgery was a treatment of last resort. Without antibiotics, we lose 150 years of clinical and surgical advances. Within ten years, we are at risk of few antibiotics being effective. It may not be the novel virus that people were expecting, but the next pandemic is already here.

[brightlotusmoon]

An incubation period is the length of time it takes someone to develop symptoms after exposure to a pathogen. The incubation period for SARS-CoV-2, the virus that causes COVID-19, has shortened considerably since the virus first began circulating, recent data suggest. Incubation periods averaged about five days when the Alpha variant was dominant, about 4.5 days when Beta and Delta were dominant, and about 3.4 days once Omicron took over, according to a 2022 research review.

Newer research from various countries, including Japan, France, and Singapore, also suggests Omicron strains have incubation periods of about three days, or even a little less.

The virus' incubation period is likely shrinking for a few reasons, says Shane Crotty, chief scientific officer at the La Jolla Institute for Immunology. The virus has evolved over time, becoming faster and more adept at infecting humans, Crotty says. Nearly everyone has also now had at least one brush with COVID-19, whether through vaccination or illness. Each encounter leaves behind instructions for the immune system, helping it recognize the virus faster the next time it appears.

“You having symptoms is all about your immune system being activated,” Crotty explains. “The whole pre-symptomatic period is bad news because your immune system has not managed to pull the fire alarm yet.” A shorter incubation period means that your body is “recognizing the virus faster and pulling those sprinkler systems faster.”

#thank you Seth MacFarlane for links #wear your mask #vaccines train your immune system to fight

[thoughtportal]

Scientists at Washington University in St. Louis have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and provides results in less than a minute.

The study is available online in the journal ACS Sensors. The same group of researchers recently published a paper in the journal Nature Communications about an air monitor they had built to detect airborne SARS-CoV-2 — the virus that causes COVID-19 — within about five minutes in hospitals, schools and other public places.

The new study is about a breath test that could become a tool for use in doctors’ offices to quickly diagnose people infected with the virus. If and when new strains of COVID-19 or other airborne pathogenic diseases arise, such devices also could be used to screen people at public events. The researchers said the breath test also has potential to help prevent outbreaks in situations where many people live or interact in close quarters — for example aboard ships, in nursing homes, in residence halls at colleges and universities or on military bases.

“With this test, there are no nasal swabs and no waiting 15 minutes for results, as with home tests,” said co-corresponding author Rajan K. Chakrabarty, PhD, the Harold D. Jolley Career Development Associate Professor of Energy, Environment & Chemical Engineering at the McKelvey School of Engineering. “A person simply blows into a tube in the device, and an electrochemical biosensor detects whether the virus is there. Results are available in about a minute.”

#article #medical studies #medical news #science news #COVID-19 #COVID #pandemic

[panicinthestudio]

COVID rapidly spreads in China as government eases strict quarantine rules, December 27, 2022

China is grappling with the rapid spread of COVID-19 after the government began rolling back its zero-COVID restrictions earlier this month. Now, cases are spiraling across towns and cities, hospitals are overburdened, medical staff are outnumbered and crematoriums are running out of space. Judy Woodruff reports.

PBS NewsHour

There is no nuance left in politics or public health policy when there is either an absolute and strict inflexibility of zero COVID or wholesale dismantling of safeguards before the healthcare or support systems are prepared for the waves that have been forcibly suppressed. The political insistence on using their own less effective, non-mRNA vaccines based on the original strains rather than Delta or Omicron, coupled with a low vaccination rate of the vulnerable and elderly is not helping easing the transition at all.

The way they’ve been counting mortality from COVID diverged from nearly every other country since early 2020. A death had to be directly attributable to SARS-CoV-2 eliminating cases of many preexisting or undiagnosed conditions, chronic illnesses, and other high risk factors that may have been exacerbated by the virus which became listed as the direct cause or if they simply tested negative in the few days before dying. The policy as of this week will further limit the count only to deaths caused by pneumonia or respiratory failure after contracting COVID, in addition to dropping much of the remaining inbound quarantines and regular case counts becoming even more inconsistent with lived reality.

It appears the PRC was prepared to stay in suspended animation within an onionskin of self-isolation layers indefinitely, maintaining the appearance of control and adherence to policy that was left to different local officials to execute. Downgrading the classification removes the local, emergency-style powers to lockdown and quarantine which were used capriciously. Residential buildings, offices and commercial areas such as malls, and even theme parks could be suddenly cordoned without warning, causing panic due to the stringency of testing and knock-on effects if a positive case was found rather than fear of having contacted or contracted the virus. Becoming listed as a close contact or a complete stranger’s positive result could mean further quarantining and repeated testing, as well any change in one’s COVID passport status severely restricting mobility for work or education, travel, or even basic necessities. The protests spread because “dynamic zero” was anything but dynamic, refusing to change or amend course in preparation for a transition to an endemic or post-epidemic state. People were simply fed up and the building momentum was becoming a potential danger to a regime that had just renewed its own political mandates.

These things aren’t happening in isolation, China is also changing tact on its travel restrictions domestically and internationally. The Special Administrative Regions of Hong Kong and Macau have been trying to reopen ports and travel with the Mainland for years now for travel and economic reasons. Both were forced into accepting one-way policies where it was difficult for their citizens to enter China or even between one another, while rules were softened for travelers and politicians entering from and returning to the Mainland for short trips with the reason that the pandemic was less well-contained than within the Mainland.

As news of the highly visible current outbreak within China is continuing to emerge, the Hong Kong SAR is now proudly announcing agreements have been made with the Mainland to drop their travel restrictions posthaste. It’s being reported that many are travelling specifically for mRNA vaccines which are approved in Macau and Hong Kong.

#China #covid 19 #coronavirus #pandemic #public health #politics #Chinese Communist Party #Xi Jinping #pbs newshour #seriously #fundamentally ridiculous #bureaucracy #zero covid policy #vaccination #epidemiology #reuters #financial times #news #current events #health care

[pandemic-info]

#interesting #probiotics #prevention #COVID #study #research #Springer #bacteria

[theculturedmarxist]

Implications

Additional SARS pandemics are therefore expected, like those associated with influenza. Influenza viruses are at present vastly more diverse than SARS-CoV-2, but over decades we are likely to see significant diversification of SARS lineages, if IBV’s history is to guide us. The frequency of these future pandemics is unpredictable, as is their severity. Establishing the “SARS” category as proposed here is necessary for proper preparation for such future events.

Influenza pandemics have all been self-limiting, and early in the first COVID-19 pandemic it was regularly interpreted in a similar manner, i.e. as something that will naturally dissipate. More recently that has shifted towards an acceptance of “endemicity”, where “endemicity” is sold as a state of constant circulation that is not overtly disruptive to normal societal functioning rather than the actual scientific definition, which is constant circulation of the pathogen, and which tells us nothing about its impacts on humans.

If we are to instead view the first COVID-19 pandemic as the initial, and so far appearing to be permanent introduction of an entirely new type of pathogen (SARS) in the human population, and to accept the possibility of many novel SARS serotypes and strains appearing in the future, a rather different picture emerges. So far Omicron exhibits the lowest mortality rate of all sarbecoviruses known to have infected humans, but SARS-1 was much more severe than SARS-2, and the evolution of the first SARS2 serotype was towards more severe disease27 and current data suggests a similar trajectory within many Omicron lineages28.

Therefore it cannot be assumed that all future pandemic serotypes/strains will be “inconsequential”, or even tolerable (where “tolerable” has now been established to mean anything that does not break healthcare systems to the point where refrigeration trucks need to be called in to store the dead bodies), as subsequent iterations of viral evolution that gain a strong fitness advantage due to major antigenic innovations could revert to substantially more pathogenic states, as commentators have previously warned4,25. An understanding of the course of SARS-CoV-2 evolution so far as having already spawned two separate pandemics is needed to raise awareness of and prepare for these possibilities.

#covid 19 #sarscov2 #sars #public health

[meret118]

These vaccines are the first that aren't rolled out by the U.S. government, and without funding that was directed to public health programs in the state of emergency, the outreach is nowhere near what it was at the height of the pandemic, said Lori T. Freeman, the CEO of the National Association of County and City Health Officials (NACCHO).

. . .

All insurers are legally required to cover the COVID-19 vaccine, and the federal government is stepping in to pay for vaccines for those who lack insurance through the Bridge Access Program. But insurers have been slow to implement these vaccines into their systems, leading to the stuttered rollout of the vaccine, said Dr. William Schaffner, an infectious disease and health policy professor at Vanderbilt University Medical Center

"There have already been people who have gone to their pharmacies and physician's offices looking for the vaccine and have discovered that they haven't been covered yet, so that means they're going to have to come back again," Schaffner told Salon in a phone interview. "A vaccine deferred is often a vaccine that is never received, unfortunately."

. . .

Nationally, COVID hospitalizations have been steadily increasing since June, along with the rise of Omicron variants like EG.5 (nicknamed "Eris") and FL.1.5.1 (nicknamed Fornax.) The vaccines are predicted to work against these strains of the SARS-CoV-2 virus, which evolves naturally in ways that will sometimes render vaccines next to useless. This is why new shots must be developed with some regularity.

. . .

Meanwhile, approximately 18 million Americans have developed long COVID and data suggests that number will continue to rise with more infections. Although the immunocompromised, elderly and people with other health conditions are the most vulnerable to severe infection, COVID-19 continues to be one of the top 10 leading causes of death for children in the U.S.

This rollout, including mRNA vaccines from Pfizer and Moderna, boosts immunity toward Omicron variants. The Centers for Disease Control and Prevention (CDC) recommended the shots for everyone 6 months and up and projects that this could prevent 400,000 hospitalizations and 40,000 deaths over the next two years. 

. . .

Regardless, the question remains about how many people will take the new vaccines. Only about one in five people got last year's bivalent booster and one in four adults in the U.S. are completely unvaccinated, according to CDC data and the KFF survey. Although it has been improving over time, uptake has been particularly low in Black communities, in part because vaccination sites are disproportionately located in white neighborhoods but also because of decades of mistrust built up in response to prior medical malpractice.

Notably, just 6 million doses have been put aside for the uninsured through the Bridge Access Program, when at least 27 million people in the U.S. are uninsured, Freeman said. The demand for vaccines is a moving target that distributors are trying to balance without losing money, she added, especially because these vaccines have to be kept cold and take resources to store and administer.

-----

Absolutely get the vaccine! I recommend calling your insurance and pharmacy first though.

#COVID 19 #Health

[ayurvedsutra]

Genetic recombination made Omicron more infectious

New Delhi (India Science Wire): Viruses like SARS-CoV-2 keep changing their genetic makeup to escape human immune response. One of the ways they can change rapidly is Genetic Recombination which happens in a person co-infected with two different SARS-CoV-2 strains simultaneously. Researchers from the Department of Microbiology & Cell Biology, and the Centre for Infectious Diseases Research,…

View On WordPress

#Corona Virus #Omicron #SARS #Virus